Every Form 4 that Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IINNW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IINNW filings page.
QTREX Quantum Ltd. Chief Technology Officer Daniella Yechezkely Hayon reported an open-market sale of 50,000 Ordinary Shares at $3.00 per share. The sale followed the vesting of Restricted Share Units, where each RSU converted into one Ordinary Share. After this transaction, she directly holds 780,000 Ordinary Shares.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units. The underlying shares were then sold under an existing Rule 10b5-1 trading plan, indicating the transactions were pre-scheduled.
The reported sales included 28,100 shares at $3.50 per share on May 31, 2026 and 1,900 shares at $3.51 per share on May 29, 2026. After these transactions, Yafit directly holds 870,000 Ordinary Shares, so the disposals represent a small portion of her overall position.
QTREX Quantum Ltd. COO and VP of R&D Shabtay Abraham exercised employee stock options to acquire 95,239 Ordinary Shares on May 29, 2026. These exercises were reported as derivative transactions and did not involve any open‑market buying or selling.
Following the exercises, Abraham directly holds 1,332,713 Ordinary Shares. The options exercised came from grants made in 2020 that had fully vested by mid‑2022, with exercise prices disclosed in the footnotes in AUD and NIS terms.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales of a total of 60,000 Ordinary Shares of QTEX at prices between $2.0134 and $3.00 per share. Following these transactions, she directly holds 900,000 Ordinary Shares.
On the same dates, she exercised employee share options covering 13,605 Ordinary Shares at a conversion price of $0.12 per share, with no derivative options remaining after the exercise. The sales were executed pursuant to an existing Rule 10b5-1 trading plan, indicating they were pre-arranged rather than timed discretionarily.